Comparative effects of antacids, enteric coating, and bile salts on the efficacy of oral pancreatic enzyme therapy in cystic fibrosis.
D000293:Adolescent; D000863:Antacids / Q000008:administration & dosage; D001647:Bile Acids and Salts / Q000008:administration & dosage; D001682:Biological Availability; D002648:Child; D003550:Cystic Fibrosis / Q000188:drug therapy*; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D010179:Pancreas / Q000201:enzymology; D010194:Pancreatin / Q000008:administration & dosage*; D013608:Tablets, Enteric-Coated
D000863:Antacids; D001647:Bile Acids and Salts; D004338:Drug Combinations; D013608:Tablets, Enteric-Coated; D010194:Pancreatin